WTF does this mean from the PR: "As there are n
Post# of 148133
"As there are now several completed, ongoing, or planned randomized trials of PRO140 (leronlimab) that include severe or critical hospitalized COVID-19 patients, any integrated or meta-analysis would be strengthened if you prespecified analysis details and submitted these for review before results of ongoing or planned trials are Unblinded.’"
Sounds like the EFFDA is trying to slow down getting results from the Brazil trial.